Next week, on May 31 in American and June 1 in Europe, we will be discussing the two major AKI studies looking at the timing of renal replacement therapy:
Look for a formal background post later this week.
Background
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
Background
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
